medigraphic.com
ISSN 1561-3127 (Electronic)
ISSN 0864-3466 (Print)

2019, Number 3

<< Back Next >>

Revista Cubana de Salud Pública 2019; 45 (3)

Factors related to the control of hypertension in Cienfuegos

Morejón GAF, Benet-Rodríguez M, Bernal-Muñoz JL, Espinosa-Brito AD, Silva ALC, Ordunez P

Language: Spanish
References: 31
Page: 1-17
PDF size: 547.11 Kb.


ABSTRACT

Introduction: The control of blood pressure is a global challenge and one of the main public health problems nowadays.
Objectives: To describe the factors related to the evolution, detection and control of hypertension in Cienfuegos from 2001 to 2011 in a scenario of universal access to health services.
Methods: Population study developed during 2011, with a representative, probabilistic sample of 1276 adults in the ages from 25 to 74 years old whom lived in the city of Cienfuegos, Cuba.
Results: From the hypertensive patients, 32,8 % were unaware of their condition, 90% of those who knew their condition had treatment, and 29,8 % were controlled. Uncontrolled hypertension’s risk was significantly higher in people with age ≥ 65 years, the ones of black race or mixed race, in the ones not attending to the doctor’s consultation or not controlling the blood pressure for more than one year. In relation to 2001, the percentage of hypertensive patients who did not know their condition increased by 11,3 %; the number of treated patients was reduced by 3,4 % and the level of control by 10%.
Conclusions: There are a group of factors as age, race, and the lack of follow up to these patients in the health care services in order to detect and control hypertension that affect its behavior. The results, although better than those observed in other countries in the region, show a gap in terms of detection and control of hypertension, the follow up of the patients and management of the system in the year 2011 in comparison with the previous decade.


REFERENCES

  1. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and nationalag-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990‒2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015 Jan 10;385(9963):117-71.

  2. WHO. Global health risks: mortality and burden of disease attributable to selectedmajor risks. Geneva: World Health Organization; 2009. Acceso: 18/01/2018. Disponible en: http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf

  3. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressurefrom 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017 Jan 7;389(10064):37-55.

  4. Webster J, Waqanivalu T, Arcand J, Trieu K, Cappuccio FP, Appel LJ, et al.Understanding the science that supports population-wide salt reduction programs. J Clin Hypertens (Greenwich). 2017;19(6):569-76.

  5. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index,underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627-42.

  6. Frieden TR, Jaffe MG. Saving 100 million lives by improving global treatment ofhypertension and reducing cardiovascular disease risk factors. J Clin Hypertens (Greenwich). 2018;20(2):208-11.

  7. Olsen MH, Angell SY, Asma S, Boutouyrie P, Burger D, Chirinos JA, et al. A call toaction and a life course strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. Lancet. 2016;388(10060):2665‒712.

  8. Frieden TR, Bloomberg MR. Saving an additional 100 million lives. Lancet [Internet].2018;391(10121):709-12. Acceso: 03/03/2018. Disponible en: http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(17)32443-1.pdf

  9. Farley TA, Dalal MA, Mostashari F, Frieden TR. Deaths preventable in the U.S. byimprovements in use of clinical preventive services. Am J Prev Med. 2010;38(6):600-9.

  10. Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence,awareness, treatment, and control of hypertension in rural and urban communities in high -middle-, and low-income countries. JAMA. 2013 Sep 4;310(9):959-68.

  11. Orduñez-Garcia P, Muñoz JL, Pedraza D, Espinosa-Brito A, Silva LC, Cooper RS.Success in control of hypertension in a low-resource setting: the Cuban experience. J Clin Hypertens (Greenwich). 2006;24(5):845-9.

  12. Cooper RS, Orduñez P, Iraola Ferrer MD, Munoz JL, Espinosa-Brito A.Cardiovascular disease and associated risk factors in Cuba: prospects for prevention and control. Am J Public Health. 2006;96(1):94-101.

  13. Alderman MH. Does blood pressure control require a Cuban-style revolution? J ClinHypertens (Greenwich). 2006 May;24(5):811-2.

  14. United Nations. Transforming our world: the 2030 agenda for sustainabledevelopment [Internet]. Geneva: United Nations; 2015 Acceso: 18/01/2018. Disponible en: https://sustainabledevelopment.un.org/content/documents/21252030%20Agenda%20for%20Sustainable%20Development%20web.pdf

  15. Ordúñez P, Barceló A, Bernal JL, Espinosa A, Silva LC, Cooper RS. Risk factorsassociated with uncontrolled hypertension: findings from the baseline CARMEN survey in Cienfuegos, Cuba. J Clin Hypertens (Greenwich). 2008;26(4):663-71.

  16. Silva LC, Benet M, Morejón A, Ordúñez P. An efficient sampling approach tosurveillance of non-communicable disease risk factors in Cienfuegos, Cuba. MEDICC Rev. 2012;14(4):36-9.

  17. Ordúñez P, Kaufman JS, Benet M, Morejon A, Silva LC, Shoham DA, et al. Blacksand Whites in the Cuba have equal prevalence of hypertension: confirmation from a new population survey. BMC Public Health. 2013 Feb 24;13:169.

  18. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. andNational Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-72.

  19. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension inthe United States. N Engl J Med. 2001;16;345(7):479‒86. Erratum in: N Engl J Med. 2002;346(7):544.

  20. Pereira M, Lunet N, Azevedo A, Barros H. Differences in prevalence, awareness,treatment and control of hypertension between developing and developed countries J Clin Hypertens (Greenwich). 2009;27(5):963-75.

  21. Bonet Gorbea M, Varona Pérez P, ed. III Encuesta Nacional de Factores de Riesgoy Actividades Preventivas de Enfermedades No Transmisibles. Cuba 2010-2011. La Habana: Editorial Ciencias Médicas; 2014.

  22. Campbell N, Ordunez P, Jaffe MG, Orias M, DiPette DJ, Patel P, et al. Implementingstandardized performance indicators to improve hypertension control at both the population and healthcare organization levels J Clin Hypertens (Greenwich). 2017;19(5):456-61.

  23. Wang TJ, Vasan RS. Epidemiology of uncontrolled hypertension in the United States.Circulation. 2005 Sep 13;112(11):1651-62.

  24. 24.I ñiguez Rojas Luisa. Aproximación a la evolución de los cambios en los servicios desalud en Cuba. Rev Cub Sal Públ [Internet]. 2012;38(1):109-125. Acceso: 20/07/2018 Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 34662012000100011&lng=es

  25. Morales Ojeda R, Mas Bermejo P, Castell-Florit Serrate P, Arocha Mariño C,Valdivia Onega NC, Druyet Castillo D, et al. Transformaciones en el sistema de salud en Cuba y estrategias actuales para su consolidación y sostenibilidad. Rev Panam Salud Publica. 2018;42:e25.

  26. Franco M, Orduñez P, Caballero B, Tapia Granados JA, Lazo M, Bernal JL, et al.Impact of energy intake, physical activity, and population-wide weight loss on cardiovascular disease and diabetes mortality in Cuba, 1980‒2005. Am J Epidemiol. 2007;166(12):1374-80.

  27. Schiffrin EL, Campbell NR, Feldman RD, Kaczorowski J, Lewanczuk R, Padwal R,et al. Hypertension in Canada: Past, Present, and Future. Ann Glob Health. 2016;82(2):288-99.

  28. Jaffe MG, Lee GA, Young JD, Sidney S, Go AS. Improved blood pressure controlassociated with a large-scale hypertension program. JAMA. 2013;310(7):699-705.

  29. Angell SY, De Cock KM, Frieden TR. A public health approach to globalmanagement of hypertension. Lancet. 2015;385(9970):825-7.

  30. Patel P, Ordunez P, Di Pette D, Escobar MC, Hassell T, Wyss F, et al. and theStandardized Hypertension Treatment and Prevention Network. Improved Blood Pressure Control to Reduce Cardiovascular Disease Morbidity and Mortality: The Standardized Hypertension Treatment and Prevention Project. J Clin Hypertens (Greenwich). 2016;18(12):1284-94.

  31. Pérez Caballero MD, León Álvarez JL, Dueñas Herrera A, Alfonzo Guerra JP,Navarro Despaigne DA, de la Noval García R, et al. Guía cubana de diagnóstico, evaluación y tratamiento de la hipertensión arterial. Rev Cubana Med [Internet]. 2017;56(4):242-32. Acceso: 06/09/2018. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034- 75232017000400001&lng=es




2020     |     www.medigraphic.com